Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duvuru Geetha

Showing results (141-150 of 146) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 146 results.
Kidney International Reports|June 20, 2024
Real-World Experience With Avacopan in Antineutrophil Cytoplasmic Autoantibody-Associated VasculitisReza Zonozi, Faten Aqeel, Dustin Le, et al.
The New England Journal of Medicine|July 22, 2010
Rituximab versus cyclophosphamide for ANCA-associated vasculitisJohn H Stone, Peter A Merkel, Robert Spiera, et al.
Kidney International Reports|June 9, 2025
Clinical Presentation and Outcomes of Antineutrophil Cytoplasmic Autoantibody-Negative Pauci-Immune GlomerulonephritisLauren Floyd, Anamay Shetty, Adam D Morris, et al.
The New England Journal of Medicine|August 2, 2013
Efficacy of remission-induction regimens for ANCA-associated vasculitisUlrich Specks, Peter A Merkel, Philip Seo, et al.
Jvs-Vascular Insights|January 13, 2025
Challenges and potential solutions to enrollment in a clinical trial of arteriovenous fistula vs arteriovenous graft vascular access strategyMatthew P Goldman, Dipal M Patel, Kevin Z Chang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 23, 2024
Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis NephritisSean J Barbour, Rosanna Coppo, Lee Er, et al.
Pageof 15

Showing results (141-150 of 146) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 146 results.
Kidney International Reports|June 20, 2024
Real-World Experience With Avacopan in Antineutrophil Cytoplasmic Autoantibody-Associated VasculitisReza Zonozi, Faten Aqeel, Dustin Le, et al.
The New England Journal of Medicine|July 22, 2010
Rituximab versus cyclophosphamide for ANCA-associated vasculitisJohn H Stone, Peter A Merkel, Robert Spiera, et al.
Kidney International Reports|June 9, 2025
Clinical Presentation and Outcomes of Antineutrophil Cytoplasmic Autoantibody-Negative Pauci-Immune GlomerulonephritisLauren Floyd, Anamay Shetty, Adam D Morris, et al.
The New England Journal of Medicine|August 2, 2013
Efficacy of remission-induction regimens for ANCA-associated vasculitisUlrich Specks, Peter A Merkel, Philip Seo, et al.
Jvs-Vascular Insights|January 13, 2025
Challenges and potential solutions to enrollment in a clinical trial of arteriovenous fistula vs arteriovenous graft vascular access strategyMatthew P Goldman, Dipal M Patel, Kevin Z Chang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 23, 2024
Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis NephritisSean J Barbour, Rosanna Coppo, Lee Er, et al.
Pageof 15